Affordable Access

Access to the full text

Large subretinal hemorrhage after intravitreal bevacizumab (Avastin®) for age-related macular degeneration

Authors
  • Chieh, Jenet J.1
  • Fekrat, Sharon1
  • 1 Duke University Medical Center, Department of Opthalmology, Durham, NC , Durham
Type
Published Article
Journal
Annals of Ophthalmology
Publisher
Humana Press
Publication Date
Mar 01, 2007
Volume
39
Issue
1
Pages
51–52
Identifiers
DOI: 10.1007/BF02697326
Source
Springer Nature
Keywords
License
Yellow

Abstract

We report the development of a large subretinal hemorrhage 4 weeks after intravitreal bevacizumab in an 84-year-old male with 20/70 visual acuity caused by occult choroidal neovascularization from neovascular agerelated macular degeneration in one eye that was treated with 1.25 mg of intravitreal bevacizumab.

Report this publication

Statistics

Seen <100 times